Showing results (161-170 of 188) with videos related to
Sort By:
Pageof 19
European Journal of Pharmacology|May 11, 2022
Interaction of the preferential D<sub>3</sub> agonist (+)PHNO with dopamine D<sub>3</sub>-D<sub>2</sub> receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imagingFrancesco Petragnano, Irene Fasciani, Clotilde Mannoury la Cour, et al.Cerebral Cortex (New York, N.Y. : 1991)|June 22, 2011
Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortexPascal Fossat, Fabrice R Turpin, Silvia Sacchi, et al.Molecular Pharmacology|August 13, 2010
The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptorsElena Silvano, Mark J Millan, Clotilde Mannoury la Cour, et al.The Journal of Pharmacology and Experimental Therapeutics|May 18, 2004
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysisMark J Millan, Alain Gobert, Sylvain Roux, et al.The Journal of Pharmacology and Experimental Therapeutics|February 24, 2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropiniroleMark J Millan, Benjamin Di Cara, Michael Hill, et al.Molecular Neurobiology|September 8, 2022
Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ PeptidesLinda Hanbouch, Béatrice Schaack, Amal Kasri, et al.Science Advances|August 7, 2024
AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1Alejandro Díaz-Holguín, Marcus Saarinen, Duc Duy Vo, et al.Ebiomedicine|June 23, 2016
Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency SyndromeHélène Darville, Aurélie Poulet, Frédérique Rodet-Amsellem, et al.The Journal of Biological Chemistry|March 15, 2015
Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromersMaud Kamal, Florence Gbahou, Jean-Luc Guillaume, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 21, 2010
S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetineMark J Millan, Anne Dekeyne, Alain Gobert, et al.Pageof 19